BACE1

  • Official Full Name

    beta-site APP-cleaving enzyme 1
  • Overview

    Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimers disease. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein (APP) by two proteases, one of which is the protein encoded by this gene. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease that is found mainly in the Golgi. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]
  • Synonyms

    BACE1;beta-site APP-cleaving enzyme 1;ASP2;BACE;HSPC104;beta-secretase 1;asp 2;memapsin-2;APP beta-secretase;aspartyl protease 2;beta-site APP cleaving enzyme 1;beta-secretase 1 precursor variant 1;transmembrane aspartic proteinase Asp2;membrane-associated aspartic protease 2;beta-site amyloid beta A4 precursor protein-cleaving enzyme

Recombinant Proteins

  • Human
  • Mouse
  • Zebrafish
  • Rhesus macaque
  • Rat
  • Mus musculus
  • HEK293
  • E.coli
  • Baculovirus
  • Wheat Germ
  • Mammalian Cell
  • Human Cell
  • HEK293T
  • E. coli
  • E.coli expression system
  • Fc
  • His
  • Non
  • GST
  • Flag
  • His&GST
  • Myc&DDK
  • His&Fc&Avi
Cat.# Product name Source (Host) Species Tag Protein Length Price
BACE1-253H Active Recombinant Human BACE1 protein(Met1-Thr457), hFc-tagged HEK293 Human Fc Met1-Thr457
Bace1-252M Active Recombinant Mouse Bace1 protein(Met1-Thr457), His-tagged HEK293 Mouse His Met1-Thr457
BACE1-255H Active Recombinant Human BACE1 protein HEK293 Human Non Met1-Thr457
BACE1-891H Recombinant Human BACE1 protein, His-tagged HEK293 Human His Thr22-Thr457
BACE1-0398H Recombinant Human BACE1 protein, His-tagged E.coli Human His 157-457 aa
BACE1-13H Recombinant Human beta-site APP-cleaving enzyme 1 Protein, His tagged Baculovirus Human His 22-457aa
BACE1-002H Recombinant Human BACE1 protein, Fc-tagged HEK293 Human Fc Thr22-Thr457
BACE1-003H Recombinant Human BACE1 protein HEK293 Human Thr22-Thr457
BACE1-102H Recombinant Human BACE1, GST-tagged Wheat Germ Human GST
BACE1-11726Z Recombinant Zebrafish BACE1 Mammalian Cell Zebrafish His
BACE1-1661H Recombinant Human Beta-Site APP-Cleaving Enzyme 1 E.coli Human Non
BACE1-219H Recombinant Human BACE1, C13&N15-labeled HEK293 Human Non 22-457 a.a.
BACE1-26297TH Recombinant Human BACE1 E.coli Human Non 28-393 a.a.
BACE1-27426TH Recombinant Human BACE1, FLAG-tagged Human Flag
BACE1-31H Recombinant Human Beta-Site APP-Cleaving Enzyme 1 E.coli Human Non 28-393 a.a.
BACE1-503R Recombinant Rhesus monkey BACE1 Protein, His-tagged Mammalian Cell Rhesus macaque His
BACE1-713H Recombinant Human BACE1 protein, His & GST-tagged E.coli Human His&GST Phe170~Thr428
Bace1-714M Recombinant Mouse Bace1 protein, His & GST-tagged E.coli Mouse His&GST Pro190~Ala430
Bace1-715R Recombinant Rat Bace1 protein, His-tagged E.coli Rat His Gly181~Tyr366
BACE1-929R Recombinant Rat BACE1 Protein Mammalian Cell Rat His
BACE1-3006HCL Recombinant Human BACE1 cell lysate Human Cell Human Non
BACE1-3077MCL Recombinant Mouse BACE1 cell lysate Human Cell Mouse Non
BACE1-0360H Recombinant Human BACE1 Protein (Glu46-Thr457), N-His-tagged E.coli Human His Glu46-Thr457
Bace1-1815M Recombinant Mouse Bace1 Protein, Myc/DDK-tagged HEK293T Mouse Myc&DDK
BACE1-2200H Recombinant Human BACE1 Protein, MYC/DDK-tagged HEK293 Human Myc&DDK
BACE1-2682H Recombinant Human BACE1 Protein, Myc/DDK-tagged, C13 and N15-labeled HEK293T Human Myc&DDK
BACE1-2685H Recombinant Human BACE1 protein, His-tagged HEK293 Human His Thr22-Tyr460
BACE129323H Recombinant Human BACE1 (22-446) (R56T, R57T) Protein, His-tagged E.coli Human His
BACE1-2938H Active Recombinant Human BACE1 protein HEK293 Human Non Thr 22-Thr 457
BACE1-2939H Recombinant Human BACE1 protein, Fc-tagged HEK293 Human Fc Thr 22-Thr 457
BACE1-2940H Active Recombinant Human BACE1 protein, His-tagged HEK293 Human His Thr 22-Thr 457
BACE1-331R Recombinant Rhesus Macaque BACE1 Protein, His (Fc)-Avi-tagged HEK293 Rhesus macaque His&Fc&Avi
BACE1-331R-B Recombinant Rhesus Macaque BACE1 Protein Pre-coupled Magnetic Beads HEK293 Rhesus macaque
BACE1-587R Recombinant Rat BACE1 Protein, His (Fc)-Avi-tagged HEK293 Rat His&Fc&Avi
BACE1-587R-B Recombinant Rat BACE1 Protein Pre-coupled Magnetic Beads HEK293 Rat
BACE1-6791H Recombinant Human BACE1 protein E. coli Human Non 454aa
BACE1-779H Recombinant Human BACE1 Protein HEK293 Human 501
BACE1-780H Recombinant Human BACE1 Protein, Fc-tagged HEK293 Human Fc 501
BACE1-781H Recombinant Human BACE1 Protein HEK293 Human 501
RFL25174MF Recombinant Full Length Mouse Beta-Secretase 1(Bace1) Protein, His-Tagged E.coli expression system Mus musculus His Full L. Full Length of Mature Protein (46-501)
RFL27958RF Recombinant Full Length Rat Beta-Secretase 1(Bace1) Protein, His-Tagged E.coli expression system Rat His Full L. Full Length of Mature Protein (46-501)
RFL3660HF Recombinant Full Length Human Beta-Secretase 1(Bace1) Protein, His-Tagged E.coli expression system Human His Full L. Full Length of Mature Protein (46-501)

    Background

    What is bace1 protein?

    BACE1, or Beta-Secretase 1, is an enzyme that plays a crucial role in the formation of amyloid beta, a protein heavily implicated in the pathology of Alzheimer's disease. BACE1 is involved in the amyloidogenic pathway, where it cleaves the amyloid precursor protein (APP) at the beta-site, leading to the production of amyloid beta peptides.

    Amyloid beta peptides can aggregate to form insoluble fibrils and plaques in the brain, which are characteristic features of Alzheimer's disease. These plaques are believed to disrupt cell-to-cell communication and activate immune system cells that trigger inflammation and devour disabled cells.

    Inhibiting the activity of BACE1 has been a target for Alzheimer's disease therapy, aiming to reduce the production of amyloid beta and hence its accumulation in the brain. However, developing effective and safe BACE1 inhibitors has been challenging due to the enzyme's other roles in the body and the complex nature of Alzheimer's disease.

    What is the function of bace1 protein?

    Cleaving Amyloid Precursor Protein (APP): BACE1 cleaves APP at the beta-site. This cleavage is the first step in the production of amyloid beta peptides. After BACE1 cleaves APP, another enzyme, gamma-secretase, further processes the resulting fragments to produce amyloid beta peptides.

    Role in Amyloid Beta Peptide Formation: The amyloid beta peptides formed by the action of BACE1 and gamma-secretase can accumulate and form insoluble fibrils and plaques in the brain, which are hallmarks of Alzheimer's disease. These plaques are believed to disrupt neuronal communication, contribute to neuronal death, and trigger inflammatory responses in the brain.

    Implications in Alzheimer's Disease: Due to its role in amyloid beta production, BACE1 is a significant target for Alzheimer's disease research. Inhibiting BACE1 activity is considered a potential therapeutic strategy to reduce amyloid beta levels and mitigate the progression of Alzheimer's disease.

    Other Biological Roles: Beyond its role in the production of amyloid beta, BACE1 is involved in other biological processes. It cleaves other protein substrates and is involved in myelination and neuronal development. These additional roles of BACE1 highlight the complexity of targeting it for therapeutic purposes, as inhibiting BACE1 could have unintended effects beyond reducing amyloid beta production.

    Bace1 related signaling pathway

    Amyloid Precursor Protein (APP) Processing:

    APP, a transmembrane protein, can undergo processing through two distinct pathways: the non-amyloidogenic pathway and the amyloidogenic pathway. The non-amyloidogenic pathway involves the cleavage of APP by α-secretase, which precludes the formation of amyloid beta. In the amyloidogenic pathway, APP is first cleaved by β-secretase, of which BACE1 is a key enzyme.

    Role of BACE1:

    BACE1 cleaves the extracellular portion of APP at the beta-site, producing a soluble fragment (sAPPβ) and a membrane-bound fragment (C99). This cleavage by BACE1 is the initial step in the amyloidogenic pathway and is crucial for the subsequent production of amyloid beta peptides.

    Further Processing by γ-Secretase:

    The C99 fragment left in the membrane after BACE1 cleavage is then processed by γ-secretase. γ-Secretase cleaves this fragment to release amyloid beta peptides of varying lengths, with amyloid beta 40 and amyloid beta 42 being the most common forms.

    Bace1 Related Diseases

    Alzheimer's Disease (AD):

    The most well-known association of BACE1 is with Alzheimer's disease. BACE1 is involved in the initial step of the amyloidogenic pathway, cleaving the amyloid precursor protein (APP) and leading to the production of amyloid beta (Aβ) peptides. Accumulation of Aβ peptides, particularly Aβ42, leads to the formation of amyloid plaques, a hallmark of Alzheimer's pathology. These plaques contribute to neurodegeneration and the cognitive decline seen in Alzheimer's patients.

    Cerebral Amyloid Angiopathy (CAA):

    CAA is a condition characterized by the deposition of amyloid beta in the walls of the cerebral arteries. This condition can lead to cerebral hemorrhage and is often found in Alzheimer's disease patients. Since BACE1 is involved in the production of amyloid beta, its activity is also associated with the pathogenesis of CAA.

    Down Syndrome:

    Individuals with Down Syndrome (trisomy 21) have an extra copy of chromosome 21, which includes the APP gene. Overexpression of APP can lead to increased production of amyloid beta due to more substrate being available for BACE1. This is one reason why individuals with Down Syndrome are at a higher risk of developing early-onset Alzheimer's disease.

    Biomedical Application of bace1 Protein

    •  BACE1 Inhibitors: Given its crucial role in the production of amyloid beta peptides, BACE1 is a major target for Alzheimer's disease drug development. Inhibitors of BACE1 aim to reduce the production of amyloid beta, potentially slowing the progression of Alzheimer's disease. Several BACE1 inhibitors have been developed and tested in clinical trials.
    •  Disease Modification: By targeting a key step in the amyloidogenic pathway, BACE1 inhibitors could potentially modify the course of Alzheimer's disease, rather than merely treating symptoms. This represents a significant shift in the therapeutic approach to this condition.
    •  Diagnostic Tool: Changes in BACE1 activity or levels in the body could serve as biomarkers for the early detection of Alzheimer's disease. Research is ongoing to determine if measuring BACE1 activity in blood or cerebrospinal fluid can provide a reliable diagnostic tool.

    Case Study

    BACE1 levels are reduced.jpg

    (Katherine R Sadleir, 2015)

    Fig2. BACE1 levels are reduced by ~50% in 5XFAD/BACE1 +/− mice. (A) 20 μg of protein/lane of brain homogenates of 4, 6, and 9 month-old 5XFAD/BACE1+/+, 5XFAD/BACE1+/− or 5XFAD/BACE1−/− (as a negative control) female (F) and male (M) mice were separated by SDS-PAGE, transferred onto PVDF membrane, stained with Ponceau S, and incubated with BACE-Cat1 monospecific antibody against BACE1 [28] followed by HRP-conjugated secondary antibody and chemiluminescence imaging. Representative BACE1 immunoblot and Ponceau S staining of brain homogenates from 4 month-old mice is shown. Note the absence of BACE1 immunosignal in the BACE1−/− lane.

    Analysis of BACE1 shedding and extracellular release of BACE1 holoproteins.jpg

    (Kiyoko S. Murayama , 2005)

    Fig3. Analysis of BACE1 shedding and extracellular release of BACE1 holoproteins. Immunoblot analysis of the BACE1 CTF. Membrane proteins from SH-BA cells were separated on 16% Tris–Tricine gels and immunoblotted with a mouse monoclonal 1D4 antibody

    Quality Guarantee

    High Purity

    SDS-PAGE BACE1-891H.jpg

    Fig1. SDS-PAGE (Cat. No.: BACE1-891H)

    Involved Pathway

    BACE1 involved in several pathways and played different roles in them. We selected most pathways BACE1 participated on our site, such as Alzheimers disease, which may be useful for your reference. Also, other proteins which involved in the same pathway with BACE1 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.

    Pathway Name Pathway Related Protein
    Alzheimers disease COX7B2,UQCRH,TNF,APOE,APAF1,CDK5,ATP5C1,NDUFS4,COX7C,CAPN2

    Protein Function

    BACE1 has several biochemical functions, for example, aspartic-type endopeptidase activity,beta-amyloid binding,beta-aspartyl-peptidase activity. Some of the functions are cooperated with other proteins, some of the functions could acted by BACE1 itself. We selected most functions BACE1 had, and list some proteins which have the same functions with BACE1. You can find most of the proteins on our site.

    Function Related Protein
    protein binding SPATA7,PVRL1,LBH,ADCK5,ZNF695,LEPROT,STK40,MRPL15,SOX1,ENTPD3
    beta-amyloid binding MAPK8IP2,APOEB,TSSK1B,CHRNA7,ARMCX5-GPRASP2,GPRASP2,APOEA,HSD17B10,CLSTN1,APBB2
    peptidase activity ADAM25,OTUD5A,SPINT1A,MMP23BB,PCSK7,GZMF,USP12A,BMP1,NOTS,FURINB
    aspartic-type endopeptidase activity REN,BACE2,DDI1,ATP6AP2,ASPRV1,Casp3,SPPL3,CNTNAP5A,PIP,PGC
    enzyme binding TAF10,SLC12A3,PRMT1,PRKCD,PRKCH,DDC,HLCS,KRT79,ZFHX3,CAT

    Interacting Protein

    BACE1 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with BACE1 here. Most of them are supplied by our site. Hope this information will be useful for your research of BACE1.

    Clec4g;FLOT2;APP;Flot1;FLOT1;MMP2;CSNK1D;App

    Resources

    References

    • Sadleir, KR; Eimer, WA; et al. A beta reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level. Molecular Neurodegeneration 10:-(2015).
    • Yu, YJ; Atwal, JK; et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates. SCIENCE TRANSLATIONAL MEDICINE 6:-(2014).

    Ask a Question for All BACE1 Products

    Required fields are marked with *

    My Review for All BACE1 Products

    Required fields are marked with *